Stay updated with breaking news from David Odde. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The US study is the first published randomised control trial to suggest medication taken during the acute phase of Covid may be able to reduce the risk of long Covid.
A two-week course of the safe, affordable diabetes medication, metformin, following a positive Covid test could reduce risk of long Covid by 40 per cent over the subsequent 10 months, a study published in The Lancet Infectious Diseases journal found.
A two-week course of the safe, affordable diabetes medication, metformin, following a positive Covid test could reduce risk of long Covid by 40 per cent over the subsequent 10 months, a study published in The Lancet Infectious Diseases journal found.
Taking a two-week course of metformin, a safe and affordable diabetes medication, after testing positive for SARS-CoV-2, may lead to 40 per cent fewer long Covid risk, according to a results of trial published in The Lancet Infectious Diseases ...
The trial is the first to suggest medication after testing positive for coronavirus may be able to reduce the risk of long Covid, researchers say.